Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control.
Rathjens FS, Blenkle A, Iyer LM, Renger A, Syeda F, Noack C, Jungmann A, Dewenter M, Toischer K, El-Armouche A, Müller OJ, Fabritz L, Zimmermann WH, Zelarayan LC, Zafeiriou MP.
Rathjens FS, et al.
Cardiovasc Res. 2021 Jul 7;117(8):1908-1922. doi: 10.1093/cvr/cvaa239.
Cardiovasc Res. 2021.
PMID: 32777030
Free PMC article.